Event Description
COVID From the Translational Science/Pre-clinical/Clinical Care Research Perspectives
Topic
Translational Science Perspective
Presented By:
Elias Haddad, PhD, Professor of Medicine and Microbiology & Immunology (IMPACC: Immunophenotyping Assessment in a COVID-19 Cohort)
Faculty Moderator:
Cecilia Smith, DO, Professor and Interim Academic Chair, Department of Medicine
Register for this event
Learning Objectives
- Recognize and describe the updated presentation of SARS-CoV2.
- Update and inform the physician of the progress made with COVID vaccines and therapies in the past years.
- Analyze the information obtained and aim to determine how certain immunological measures correspond to the clinical severity of COVID-19.
Target Audience:
Drexel University faculty and affiliate generalists, specialists, fellows, residents, medical students, nurses, nurse practitioners and physician assistants.
Accredidation Statement:
Drexel University College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Drexel University College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AOA:
This program is eligible for 1 credit in Category 2A of the American Osteopathic Association. Faculty Disclosure Statement:
It is the policy of Drexel University College of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational programs. Speakers at continuing medical education activities are required to disclose to the audience any financial relationships with ineligible companies (which is any entity producing, marketing, reselling, or distributing health care goods or services consumed by or used on patients). Any conflicts of interest must be resolved prior to the presentation and announced to the audience. The intent of this disclosure is to allow participants to form their own judgments about the educational content of this activity and determine whether the speaker’s commercial interests influenced the presentation. In addition, speakers are required to openly disclose any off-label, experimental or investigational use of drugs or devices discussed in their presentation. Faculty Disclosure:
Elias Haddad, PhD, Michele Kutzler, PhD, and Stephen Anthony Pagkalinawan, MD, have no financial relationships to disclose. Planning Committee Members Disclosure:
Cecilia Smith, DO, and Michele Kutzler, PhD, have no financial relationships to disclose. |
